After 360 days, TTVL had decreased noticeably, but patients who received ATG as induction agent and were set to higher tacrolimus trough levels still exhibited higher viral loads than their IL-2 RA counterparts (median [IQR] 3.79×105 c/mL [2.89×104–1.60×107 c/mL] vs. 3.42×104 c/mL [2.39×103–4.91×105 c/mL], P=0.02; Figure 2A). This evidence concerns the gene IL2 and rheumatoid arthritis.